Skopelitou, D.; Miao, B.; Srivastava, A.; Kumar, A.; Kuświk, M.; Dymerska, D.; Paramasivam, N.; Schlesner, M.; Lubiński, J.; Hemminki, K.;
et al. A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer. J. Pers. Med. 2021, 11, 262.
https://doi.org/10.3390/jpm11040262
AMA Style
Skopelitou D, Miao B, Srivastava A, Kumar A, Kuświk M, Dymerska D, Paramasivam N, Schlesner M, Lubiński J, Hemminki K,
et al. A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer. Journal of Personalized Medicine. 2021; 11(4):262.
https://doi.org/10.3390/jpm11040262
Chicago/Turabian Style
Skopelitou, Diamanto, Beiping Miao, Aayushi Srivastava, Abhishek Kumar, Magdalena Kuświk, Dagmara Dymerska, Nagarajan Paramasivam, Matthias Schlesner, Jan Lubiński, Kari Hemminki,
and et al. 2021. "A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer" Journal of Personalized Medicine 11, no. 4: 262.
https://doi.org/10.3390/jpm11040262
APA Style
Skopelitou, D., Miao, B., Srivastava, A., Kumar, A., Kuświk, M., Dymerska, D., Paramasivam, N., Schlesner, M., Lubiński, J., Hemminki, K., Försti, A., & Bandapalli, O. R.
(2021). A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer. Journal of Personalized Medicine, 11(4), 262.
https://doi.org/10.3390/jpm11040262